Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance · 1 day ago
Open | 5.40 |
High | 5.55 |
Low | 5.22 |
Mkt Cap | 747.89M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 5.17 |
52 Wk. Low | 4.71 |
52 Wk. High | 12.43 |
Related stocks
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 45.09M | 58.60% ▲ |
Net Income | -26.88M | - |
Diluted EPS | -0.03 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.02 | - |
Q1 2024 | -$0.14 | -$0.03 |
Q4 2023 | -$0.16 | -$0.19 |
S&P 500^GSPC | 5,109.00+44.80 (+0.88%) |
Dow 30^DJI | 38,607.00+381.34 (+1.00%) |
Nasdaq^IXIC | 16,095.80+254.84 (+1.61%) |
Apple Inc.AAPL | 184.17+6.44% |
Amgen Inc.AMGN | 315.12+13.20% |
74.33-16.45% |